Internuclear Ophthalmoplegia: Evaluation and Management
For acute internuclear ophthalmoplegia (INO), obtain MRI of the brain without and with contrast including high-resolution T2-weighted images of the brainstem immediately, as the primary differential is demyelinating disease (multiple sclerosis) in younger patients and stroke in older patients 1.
Age-Based Diagnostic Approach
The etiology of INO is highly age-dependent and should guide your evaluation:
Younger Patients (<50 years)
- Primary consideration: Multiple sclerosis - demyelinating plaques affecting the medial longitudinal fasciculus (MLF) 1
- Bilateral INO in young patients is a "red flag" for MS or central demyelinating events 2
- Even with negative initial MRI, pathognomonic clinical findings supersede imaging - the MLF is microscopic and highly myelinated, so small inflammatory lesions may fall below MRI resolution 2
Older Patients (>50 years)
- Primary consideration: Ischemic stroke affecting the MLF 1
- Evaluate cardiovascular risk factors: hypertension, diabetes, hyperlipidemia, smoking 3
Other Etiologies to Consider
Clinical Examination Essentials
Look for these pathognomonic findings:
- Failure of adduction in the affected eye on horizontal gaze
- Dissociated abduction nystagmus in the contralateral eye
- Impaired convergence (distinguishes INO from isolated CN VI palsy)
- Bilateral INO may present with exotropia (WEBINO syndrome) 6
Critical associated findings to assess 3:
- Nystagmus patterns
- Horner's syndrome
- Other cranial nerve palsies
- Hemiparesis or sensory loss
- Ataxia
- Papilledema or optic atrophy
- Visual field defects
Imaging Protocol
MRI is mandatory and superior to CT 1, 4:
- Brain MRI without and with contrast
- Must include small field-of-view high-resolution T2-weighted images of the brainstem and cranial nerves 1
- Diffusion-weighted imaging to detect acute infarction 5, 6
- Spinal cord imaging if MS suspected (look for additional demyelinating lesions) 7
CT has no role except to exclude hemorrhage or if MRI is contraindicated 4.
Management Algorithm
Acute Phase (First 48 Hours)
If stroke suspected (older patient, acute onset, vascular risk factors):
- Refer immediately for stroke protocol evaluation
- Consider vascular imaging (CTA/MRA) if indicated by stroke team 1
If demyelination suspected (younger patient, bilateral INO, subacute onset):
- High-dose IV methylprednisolone empirically while awaiting MRI 2, 7
- CSF analysis for oligoclonal bands 7
- Serum inflammatory markers and autoimmune panel
- Consider infectious workup (Lyme disease, fungal, TB) if appropriate epidemiology 7
Symptomatic Management of Diplopia
Initial conservative approach 8:
- Occlusion (most commonly prescribed - 45.5% of cases) 8
- Prism therapy (24.2% of cases) - Fresnel prisms for temporary relief 3
- 30% of patients require no intervention if asymptomatic 8
Observation period: Wait 6 months for spontaneous resolution before considering surgery 3
Surgical Intervention
Reserved for persistent diplopia after 6 months 3, 8:
- Strabismus surgery can restore binocular single vision
- May require Fresnel prism post-operatively
- Goals: reduce vertical and torsional diplopia, reduce perceived visual field tilt, resolve head tilt 3
- Only 2 documented surgical cases in recent literature - not routine 8
Common Pitfalls
- Don't dismiss negative MRI in the presence of pathognomonic findings - clinical examination trumps imaging for INO 2
- Don't confuse with CN VI palsy - test convergence, which is impaired in INO but preserved in CN VI palsy
- Don't delay imaging - acute bilateral INO in young patients demands urgent MS workup
- Don't assume trauma is the only cause in young patients - MS can present after minor head trauma 7